Home » NOVARTIS, ALNYLAM JOIN HANDS FOR NEW FLU TREATMENT
NOVARTIS, ALNYLAM JOIN HANDS FOR NEW FLU TREATMENT
Pharmaceutical companies Novartis AG and Alnylam Pharmaceuticals Tuesday announced that they have joined hands to develop a new flu treatment, using a gene level therapy developed by the latter.
Newratings (http://www.newratings.com/analyst_news/article_1211443.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May